D. Liang

Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.

B. Zhang, Xianjun Yu, S. Ji, 2016, Molecular cancer research : MCR.

ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer

P. Chiao, Daming Gao, Hu Zhou, 2015, Cell Research.

A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism.

B. Zhang, J. Long, Xianjun Yu, 2017, International journal of oncology.

Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?

B. Zhang, Xianjun Yu, S. Ji, 2018, Cellular and Molecular Life Sciences.

Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going

Xianjun Yu, S. Ji, Jin Xu, 2017, Experimental & Molecular Medicine.